Conversely, miR-29b inhibitor abrogates cell growth inhibition induced by EZH2 inhibitor, indicating that suppression of miR-29b mediates EZH2-driven MM cell growth and survival55. This evidence concerns the gene EZH2 and Miyoshi myopathy.